Volatility Stories

Capstone Green Energy, a notable player in the Specialty Industrial Machinery industry, has been experiencing significant volatility in its stock price. However, as this high volatility begins to stabilize, the company presents an attractive investment opportunity. With a market value of approximately $0.59 billion, Capstone's stock has been under the close watch of analysts who have a strong buy consensus on the stock.

Arrowmark Financial Corp, an asset management company operating in the financial services sector and capital markets, has recently been displaying low volatility in the USA stock market. This characteristic is often considered a promising indicator for investors, as it suggests stability and less risk associated with the stock. As of the fiscal year end in December, the valuation market value for Arrowmark Financial Corp was at $16.85, closely aligning with the valuation hype value of $16.87.

AN2 Therapeutics (Ticker: ANTX), a notable player in the healthcare sector listed on NASDAQ, has recently been the subject of considerable discussion among investors and analysts alike. The company's stock has been characterized by its volatility, which is now seemingly on a downward trend. The question arises - is AN2 Therapeutics becoming a more stable investment opportunity? The company's valuation hype value stands at 13.9, while its real value is estimated at 16.94.

Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, has been under the spotlight recently due to its volatile stock performance. The company, which is known for developing targeted radiotherapies to treat patients with high unmet medical needs, has seen its stock price fluctuate significantly over the past few months. As of the fiscal year end in December, the company reported a loss, reflecting the challenges faced in the biotechnology industry.

In the midst of a turbulent market, Yellow Corp (NASDAQ: YELL) has been a beacon of stability, outperforming many of its peers in the Road & Rail industry. Despite the broader market downturn, the trucking company has showcased strong resilience, with a daily balance of power at 0.3895 and a rate of daily change at 1.2. The stock's typical price for the day stands at $3.82, slightly above its median price of $3.76.

Powell Industries, a prominent player in the Electrical Equipment sector, has been exhibiting dynamic market performance on the NASDAQ exchange, creating unique investment opportunities. Despite the overall analyst consensus being a 'Hold' with one hold recommendation, the company's stock volatility presents potential for both downside and upside price movements. The possible downside price is projected at $68.54, while the potential upside could reach as high as $79.55.

In the midst of a turbulent market, Evelo Biosciences, Inc., a clinical-stage biotechnology company, has demonstrated remarkable resilience and potential for investment. With a focus on developing oral medicines that act on immune cells in the small intestine with systemic effects, Evelo Biosciences has made significant strides in the biotechnology industry. The company's lead product candidate, EDP1815, has completed a Phase 2 trial for the treatment of psoriasis and is currently in a Phase 2 clinical trial for the treatment of atopic.

Tupperware Brands (TUP), a key player in the Household Goods sector within the Consumer Cyclical category, has shown a significant volatility in its stock performance throughout September. The company's market value stood at $3.67, a stark contrast to its real value of $4.58, indicating a potential undervaluation. The overall consensus among analysts is to 'Hold' the stock, with one analyst maintaining this position.

As we approach September, investors are anticipating a potential downtrend in the high volatility of Vita Coco (NASDAQ: COCO), a prominent player in the Consumer Defensive sector, specifically in the Beverages category. The company, which has its fiscal year end in December, currently holds a market valuation of $25.07, slightly above its real value of $23.63. Despite the anticipated volatility, analysts maintain a 'Buy' consensus with six strong buys and one hold.

Detailed assessment

Check Cap Ltd. operates within the Health Care Equipment & Supplies sector, and is part of the broader Health Care industry. The company has a performance score of 19 on a scale of zero to one hundred. It has a Beta (a measure of market volatility) of 1.5407, indicating a somewhat significant risk relative to the market.